Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Oct;18(4):885-94.
doi: 10.1007/s12253-012-9518-8. Epub 2012 Mar 18.

Prognostic value of TOP2A gene amplification and chromosome 17 polysomy in early breast cancer

Anna Zaczek  1 , Aleksandra Markiewicz, Anna Supernat, Natalia Bednarz-Knoll, Burkhardt Brandt, Barbara Seroczyńska, Jarosław Skokowski, Jolanta Szade, Piotr Czapiewski, Wojciech Biernat, Marzena Wełnicka-Jaśkiewicz, Jacek Jassem
Affiliations
Free article

Prognostic value of TOP2A gene amplification and chromosome 17 polysomy in early breast cancer

Anna Zaczek et al. Pathol Oncol Res. 2012 Oct.
Free article

Abstract

The aim of this study was to analyze the occurrence of TOP2A gene amplification and chromosome 17 polysomy in patients with early breast cancer and to correlate the status of these alterations with the prognostic significance expressed as patients' clinical features and survival. Such concurrent analyses of TOP2A gene status and chromosome 17 polysomy have not been performed before. Study group included 149 consecutive stage I-III patients administered standard multimodality treatment. TOP2A abnormalities were examined by standard fluorescence in situ hybridization (FISH) and developed by our group quantitative real-time PCR (qPCR). TOP2A amplification and deletion assessed by FISH were found in 23% and 7% of the tumours, respectively, and by qPCR in 31% and 11% of the tumours, respectively. Chromosome 17 polysomy was detected in 40% of the cases. TOP2A amplification (by qPCR) correlated with shorter disease-free survival (p = 0.03) and overall survival (p = 0.047), and the prognostic value of TOP2A was confirmed in the multivariate analysis (HR = 3.22, 95% CI 1.09-9.56, p = 0.03). TOP2A gene amplification, but not chromosome 17 polysomy, carries negative prognostic information in early breast cancer. Given the aforementioned results, qPCR might serve as a prognostic tool in determining the patient's prognosis.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Acta Oncol. 2008;47(4):725-34 - PubMed
    1. J Clin Oncol. 2008 Nov 1;26(31):5027-35 - PubMed
    1. J Clin Oncol. 2008 Oct 20;26(30):4869-74 - PubMed
    1. Cancer. 2001 Apr 25;93(2):165-70 - PubMed
    1. Breast Cancer Res Treat. 2007 Dec;106(2):181-9 - PubMed

Publication types

MeSH terms